The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Dynamic imaging of PEGylated indocyanine green (ICG) liposomes within the tumor microenvironment using multi-spectral optoacoustic tomography (MSOT)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565 · cited 1×
“The liposome systems ranged between 100 and 150 nm, enabling observations of enhanced permeation and retention [43].”
BackgroundExploiting the enhanced permeability and retention effect for tumor targeting
Iyer, A. K., Khaled, G., Fang, J., & Maeda, H. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.07.005 · Cited by 1,846 · cited 1×
“some tumors, infarcted or inflamed sites, disrupted bloodebrain barrier) via the enhanced permeation and retention (EPR) effect [8].”
BackgroundLiposome imaging agents in personalized medicine
Petersen, A. L., Hansen, A. E., Gabizon, A., & Andresen, T. L. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.003 · Cited by 164 · cited 1×
“The use of radiotracers for PET and SPECT imaging has been considered as a higher sensitivity alternative to MRI and CT [11,16].”
Method
Cited by
Challenges and strategies in anti-cancer nanomedicine development: An industry perspective
Hare, J. I., Lammers, T., Ashford, M. B., Puri, S., Storm, G., & Barry, S. T. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.025 · Cited by 1,214
Noninvasive Imaging of Nanomedicines and Nanotheranostics: Principles, Progress, and Prospects
Kunjachan, S., Ehling, J., Storm, G., Kiessling, F., & Lammers, T. (2015) · Chemical Reviews · doi:10.1021/cr500314d · Cited by 480
Indocyanine green-incorporating nanoparticles for cancer theranostics
Wang, H., Li, X., Tse, B. W.-C., Yang, H., Thorling, C. A., Liu, Y., Touraud, M., Chouane, J. B., Liu, X., Roberts, M. S., et al. (2018) · Theranostics · doi:10.7150/thno.22872 · Cited by 378
Advanced optoacoustic methods for multiscale imaging of in vivo dynamics
Deán-Ben, X. L., Gottschalk, S., Mc Larney, B., Shoham, S., & Razansky, D. (2017) · Chemical Society Reviews · doi:10.1039/c6cs00765a · Cited by 337
Nano-sized Indocyanine Green J-aggregate as a One-component Theranostic Agent
Liu, R., Tang, J., Xu, Y., Zhou, Y., & Dai, Z. (2017) · Nanotheranostics · doi:10.7150/ntno.19935 · Cited by 116
“Compared with ICG or other ICG-encapsulated nanoparticles [23, 24, 27, 43], one of the biggest advantage of IJA for PAI is that the main PA signal peak red-shifted ~115 nm from 780 nm to 895 nm.”
BackgroundMethod
Metadata
- Authors
- Beziere, N., Lozano, N., Nunes, A., Salichs, J., Queiros, D., Kostarelos, K., & Ntziachristos, V.
- Venue
- Biomaterials
- Publisher
- Elsevier BV
- Published
- 2015-01
- Volume
- 37
- Pages
- 415-424
- ISSN
- 0142-9612 (ISSN-L)
- OpenAlex
- W2044840613
- Cited by
- 191
- References
- 3
- FWCI
- 8.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.